Xylem (NYSE:XYL – Get Free Report) updated its FY 2026 earnings guidance on Tuesday. The company provided earnings per share (EPS) guidance of 5.550-5.700 for the period, compared to the consensus EPS estimate of 5.530. The company issued revenue guidance of $9.2 billion-$9.2 billion, compared to the consensus revenue estimate of $9.2 billion.
Xylem Stock Performance
Shares of XYL stock traded down $4.14 during trading hours on Thursday, hitting $117.99. 172,724 shares of the company were exchanged, compared to its average volume of 2,013,971. Xylem has a 52-week low of $105.29 and a 52-week high of $154.27. The company has a current ratio of 1.61, a quick ratio of 1.10 and a debt-to-equity ratio of 0.23. The firm has a fifty day simple moving average of $114.92 and a 200 day simple moving average of $122.32. The stock has a market capitalization of $28.04 billion, a price-to-earnings ratio of 28.13, a P/E/G ratio of 1.75 and a beta of 1.03.
Xylem (NYSE:XYL – Get Free Report) last released its quarterly earnings data on Tuesday, July 28th. The industrial products company reported $1.46 EPS for the quarter, beating the consensus estimate of $1.34 by $0.12. The business had revenue of $2.34 billion for the quarter, compared to the consensus estimate of $2.34 billion. Xylem had a net margin of 11.15% and a return on equity of 11.77%. The company’s revenue was up 1.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.26 earnings per share. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. Research analysts predict that Xylem will post 5.59 earnings per share for the current fiscal year.
Xylem Announces Dividend
Wall Street Analyst Weigh In
A number of analysts recently issued reports on the company. Jefferies Financial Group upgraded Xylem from a “hold” rating to a “buy” rating and boosted their price objective for the company from $130.00 to $140.00 in a research note on Thursday, June 25th. UBS Group increased their target price on shares of Xylem from $132.00 to $133.00 and gave the stock a “neutral” rating in a research note on Wednesday, April 29th. Royal Bank Of Canada lifted their price objective on Xylem from $159.00 to $164.00 and gave the company an “outperform” rating in a research note on Wednesday. Mizuho lifted their price target on Xylem from $124.00 to $130.00 and gave the company a “neutral” rating in a research report on Wednesday. Finally, Weiss Ratings lowered shares of Xylem from a “hold (c+)” rating to a “hold (c)” rating in a research report on Friday, May 8th. Nine analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $153.85.
Get Our Latest Stock Analysis on XYL
Insider Buying and Selling at Xylem
In other news, Director Jerome A. Peribere acquired 1,210 shares of the stock in a transaction dated Monday, May 4th. The stock was purchased at an average cost of $116.61 per share, with a total value of $141,098.10. Following the completion of the purchase, the director owned 27,209 shares in the company, valued at approximately $3,172,841.49. The trade was a 4.65% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, CAO Geri-Michelle Mcshane sold 4,269 shares of the business’s stock in a transaction dated Thursday, May 7th. The shares were sold at an average price of $117.46, for a total value of $501,436.74. Following the transaction, the chief accounting officer owned 3,605 shares in the company, valued at approximately $423,443.30. This represents a 54.22% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 0.32% of the company’s stock.
Institutional Inflows and Outflows
Several institutional investors have recently made changes to their positions in XYL. Balyasny Asset Management L.P. grew its stake in Xylem by 346.2% in the third quarter. Balyasny Asset Management L.P. now owns 712,950 shares of the industrial products company’s stock worth $105,160,000 after purchasing an additional 553,152 shares during the period. Adage Capital Partners GP L.L.C. bought a new position in shares of Xylem during the second quarter valued at approximately $64,407,000. Schroder Investment Management Group lifted its holdings in shares of Xylem by 29.8% during the fourth quarter. Schroder Investment Management Group now owns 1,548,508 shares of the industrial products company’s stock valued at $210,876,000 after purchasing an additional 355,826 shares during the last quarter. Lazard Asset Management LLC grew its stake in shares of Xylem by 844.4% in the 2nd quarter. Lazard Asset Management LLC now owns 392,440 shares of the industrial products company’s stock worth $50,765,000 after buying an additional 350,887 shares during the last quarter. Finally, Zurich Insurance Group Ltd FI purchased a new stake in shares of Xylem in the 3rd quarter worth approximately $45,172,000. Institutional investors own 87.96% of the company’s stock.
Xylem Company Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
Featured Stories
- Five stocks we like better than Xylem
- DoorDash’s Drone Certification Could Reshape Its Delivery Margins
- 2 Unique Space ETFs That Could Upend the Industry
- Corning Stock Crashes on Earnings, But the Sell-Off Looks Overdone
- Palantir’s Earnings Setup Puts Its AI Growth Story Back on Trial Again
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
